The global weight-loss drug market is entering a new phase, driven by the arrival of oral options, looming generic rivals and falling U.S. prices for blockbuster treatments from Eli Lilly and Novo ...

The Collaboration Framework marks Adial’s first step towards commercial partnership and establishing an exclusive European ...

Manufacturing and Supply Chain Readiness : The Company has secured agreements with leading U.S. manufacturers, including Thermo Fisher Scientific and Cambrex, to support a secure supply chain for the ...

Tevogen ('Tevogen Bio Holdings Inc.” or 'Company”) (Nasdaq: TVGN) today announced that it has entered into a signed, non-exclusive, non-binding Letter of Intent ('LoI”) to evaluate a potential ...

Alnylam pens this deal with Tenaya as it looks to replicate the sales of its blockbuster ATTR-CM therapy, Amvuttra.

Bora manufactures more than 20 commercial products for GSK at its Mississauga facility, supporting infectious disease, mental health, dermatology, & other critical therapeutic areas GSK is the largest ...

BERLIN, March 3 (Reuters) - Swiss pharmaceutical company Roche is aiming for a double-digit market share in the weight loss ...

The acquisition aims to accelerate the development of targeted therapies for EGFR mutant NSCLC patients globally.

Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry. In today’s Pharmaceutical Executive Daily, ...

Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But ...

The CNBC Changemakers and Power Players podcast features conversations with leaders shaping the future of business, policy, and culture. In this episode, CNBC's Julia Boorstin sits down with Johanna ...